Peter S.
- Country
- Germany
- Department
- Universitätsklinik für Neurologie und Neurogeriatrie
Research Overview
- A phase 2b, multinational, randomized, double-blind study to investigate the efficacy and safety of redasemtide (S-005151) compared with placebo in adult participants with acute ischemic stroke
- Safety and Efficacy of intra-arterial Tenecteplase for non-complete reperfusion of intracranial occlusion
- Evaluation of Sovateltide Efficacy and Safety in Acute Cerebral Ischemic Stroke: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial
Data & Insights
Has run more than one trial at 78 of 310 partner sites.
Specializations
Acute Stroke Management
This investigator specializes in treating acute ischemic stroke, with particular emphasis on developing innovative therapeutic approaches for immediate intervention and treatment optimization.
- Emergency stroke care
- Reperfusion strategies
- Neuroprotective interventions
Their work encompasses evaluating novel therapeutic agents for improving stroke outcomes.
Interventional Neurology
The investigator focuses on advanced interventional treatments for large vessel occlusion and incomplete reperfusion following mechanical thrombectomy procedures.
- Intra-arterial therapies
- Post-thrombectomy care
- Residual occlusion management
Their expertise includes developing protocols for complex neurovascular interventions.
Stroke Prevention
Research interests extend to preventive strategies for high-risk transient ischemic attacks and secondary stroke prevention using novel therapeutic agents.
- Risk reduction strategies
- Secondary prevention
- Therapeutic innovation
The investigator evaluates new compounds for reducing recurrent stroke risk.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.